This inventor holds 1 USPTO granted patent. Top assignee: Systemix, Inc.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Brian Ford - Innovator in Xenogeneic Tissue Implantation
Introduction
Brian Ford is a notable inventor based in Sunnyvale, California. He has made significant contributions to the field of biomedical engineering, particularly in the area of tissue implantation. His innovative work focuses on the use of xenogeneic tissue to enhance medical treatments for immunocompromised hosts.
Latest Patents
Brian Ford holds a patent for a groundbreaking invention titled "Xenogeneic tissue implant in ear pinna." This patent involves the implantation of xenogeneic fetal lymph node tissue into the ear pinna of immunocompromised hosts. The procedure includes inserting the lymph node tissue and closing the incision, resulting in rapid vascularization of the tissue. Notably, this tissue can be productively infected with HIV, opening new avenues for research and treatment.
Career Highlights
Brian Ford is currently employed at Systemix, Inc., where he continues to push the boundaries of medical innovation. His work has garnered attention for its potential applications in improving the health outcomes of individuals with compromised immune systems. With a focus on practical solutions, Ford's contributions are paving the way for future advancements in the field.
Collaborations
Brian collaborates with Hideto Kaneshima, a fellow innovator in the field. Their combined expertise enhances the research and development efforts at Systemix, Inc., fostering an environment of creativity and innovation.
Conclusion
Brian Ford's work in xenogeneic tissue implantation represents a significant advancement in medical technology. His innovative approach has the potential to transform treatment options for immunocompromised patients. Through his patent and ongoing research, Ford is making a lasting impact in the field of biomedical engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile